A 6-month multispecies inhalation study with maleic anhydride.
This study was initiated to assess the safety of atmospheres containing maleic anhydride. Accordingly, rats (15/sex/group), hamsters (15/sex/group), and monkeys (3/sex/group) were treated 6 hr a day 5 days a week for 6 months. Atmospheres were generated by subliming maleic anhydride and were monitored using Tenax collection columns and gas chromatography to detect total maleic; i.e., maleic anhydride plus maleic acid. The mean analytical concentrations were 0, 1.1, 3.3, and 9.8 mg/m3 of total maleic. Dose-related signs of nasal and ocular irritation were observed at each test level in all three species; signs included discharge, sneezing, gasping, and coughing. No significant treatment-related mortality was observed in any species. While reduced weight gains were observed only in mid- and high-dose rats, their terminal body weights were greater than 90% of control values. No treatment-related effects were observed in hematology, clinical chemistry, urinalysis, and pulmonary function tests. Although microscopic evaluation of tissue revealed evidence of nasal irritation in all species, there was no evidence of systemic toxicity which was directly attributed to maleic anhydride. While the results of this study support the current ACGIH TLV and OSHA PEL of 1 mg/m3 regarding systemic toxicity, continuous exposure at this level during the day may produce some signs of irritation.
Short
R D
RD
Monsanto Company, St. Louis, Missouri 63167.
Johannsen
F R
FR
Ulrich
C E
CE
D000280:Administration, Inhalation; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D006224:Cricetinae; D005260:Female; D005663:Furans / Q000633:toxicity*; D008253:Macaca mulatta; D008297:Male; D008299:Maleic Anhydrides / Q000633:toxicity*; D009929:Organ Size / Q000187:drug effects; D051381:Rats; D012129:Respiratory Function Tests; D013045:Species Specificity; D013997:Time Factors
D005663:Furans; D008299:Maleic Anhydrides